dcvax-l
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2007 (NCT00683241)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dcvax-l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02146066 | N/A | May 21, 2014 | Northwest Biotherapeutics |
| NCT00603460 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2012 | Northwest Biotherapeutics, University of Pennsylvania |
| NCT00683241 | Phase 1 | Nov 1, 2007 | Northwest Biotherapeutics, University of California, San Francisco, University of Pennsylvania |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Northwest Biotherapeutics | For profit | 3 | 1 | 3 | 2007 |
| University of Pennsylvania | Academic/Hospital | 2 | 2 | 2 | 2007 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2007 |
3 organizations
Page 1 / 1